I see we're meeting with Maxim today, perhaps a deal is being worked. What would we expect on a buyout given ILMN paid $400m for a second rate diagnostic from Verinata? If we added $400m alone to SQNM that would value SQNM around $9. Add in a premium for MaterniT21 market penetration and we'd be looking at $11-12 or so on a buyout. Thoughts?